JPH11504657A - フラン―およびチオフェンカルボチオアミド誘導体,それらの製造,ならびにhiv―1およびhiv―1突然変異株の複製の阻害剤としてのそれらの使用 - Google Patents
フラン―およびチオフェンカルボチオアミド誘導体,それらの製造,ならびにhiv―1およびhiv―1突然変異株の複製の阻害剤としてのそれらの使用Info
- Publication number
- JPH11504657A JPH11504657A JP9520533A JP52053397A JPH11504657A JP H11504657 A JPH11504657 A JP H11504657A JP 9520533 A JP9520533 A JP 9520533A JP 52053397 A JP52053397 A JP 52053397A JP H11504657 A JPH11504657 A JP H11504657A
- Authority
- JP
- Japan
- Prior art keywords
- hiv
- compound
- reaction mixture
- methyl
- effective amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.式: (式中,XはOまたはSである)の化合物。 2.式: を有する請求項1記載の化合物。 3.式: を有する請求項1記載の化合物。 4.請求項1記載の化合物の治療的有効量および医薬的に許容される担体から なる医薬組成物。 5.請求項2記載の化合物の治療的有効量および医薬的に許容される担体から なる医薬組成物。 6.請求項3記載の化合物の治療的有効量および医薬的に許容される担体から なる医薬組成物。 7.HIV- 1感染に冒された宿主の処置方法において,請求項1記載の化合 物の治療的有効量を宿主に投与することからなる方法。 8.HIV- 1感染に冒された宿主の処置方法において,請求項2記載の化合 物の治療的有効量を宿主に投与することからなる方法。 9.HIV- 1感染に冒された宿主の処置方法において,請求項3記載の化合 物の治療的有効量を宿主に投与することからなる方法。 10.HIV- 1の複製を阻害する方法において,請求項1記載の化合物の治療 的有効量にHIV- 1を接触させることからなる方法。 11.HIV- 1の複製を阻害する方法において,請求項2記載の化合物の治療 的有効量にHIV- 1を接触させることからなる方法。 12.HIV- 1の複製を阻害する方法において,請求項3記載の化合物の治療 的有効量にHIV- 1を接触させることからなる方法。
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US565,493 | 1995-11-30 | ||
US08/565,493 | 1995-11-30 | ||
US08/565,493 US5696151A (en) | 1995-11-30 | 1995-11-30 | Compounds useful for the inhibition of the replication of HIV-1 and HIV-1 mutants |
PCT/US1996/018394 WO1997019940A1 (en) | 1995-11-30 | 1996-11-15 | Furan- and thiophenecarbothioamide derivatives, their preparation and their use as inhibitors of the replication of hiv-1 and hiv-1 mutants |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH11504657A true JPH11504657A (ja) | 1999-04-27 |
JP3027771B2 JP3027771B2 (ja) | 2000-04-04 |
Family
ID=24258853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9520533A Expired - Lifetime JP3027771B2 (ja) | 1995-11-30 | 1996-11-15 | フラン―およびチオフェンカルボチオアミド誘導体,それらの製造,ならびにhiv―1およびhiv―1突然変異株の複製の阻害剤としてのそれらの使用 |
Country Status (21)
Country | Link |
---|---|
US (1) | US5696151A (ja) |
EP (1) | EP0874839B1 (ja) |
JP (1) | JP3027771B2 (ja) |
KR (1) | KR100505841B1 (ja) |
CN (1) | CN1098847C (ja) |
AP (1) | AP902A (ja) |
AT (1) | ATE224382T1 (ja) |
AU (1) | AU704086B2 (ja) |
BR (1) | BR9611838A (ja) |
CA (1) | CA2237194C (ja) |
DE (1) | DE69623819T2 (ja) |
DK (1) | DK0874839T3 (ja) |
ES (1) | ES2183986T3 (ja) |
HK (1) | HK1016601A1 (ja) |
HU (1) | HU223660B1 (ja) |
NZ (1) | NZ324118A (ja) |
OA (1) | OA10864A (ja) |
PT (1) | PT874839E (ja) |
TW (1) | TW448169B (ja) |
WO (1) | WO1997019940A1 (ja) |
ZA (1) | ZA969490B (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017522334A (ja) * | 2014-07-24 | 2017-08-10 | バイエル・クロップサイエンス・アクチェンゲゼルシャフト | 殺真菌性ピラゾール誘導体 |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6143780A (en) * | 1999-09-17 | 2000-11-07 | Uniroyal Chemical Company, Inc. | N-arylmethylthioanilide compounds useful for the inhibition of the replication of HIV |
US6017947A (en) * | 1999-09-17 | 2000-01-25 | Brouwer; Walter Gerhard | Heterocyclic carbodithioperoxyimidic compounds useful for the inhibition of the replication of HIV |
US6498254B1 (en) * | 2001-10-29 | 2002-12-24 | Uniroyal Chemical Company, Inc. | Antiretroviral compounds and compositions |
US7064139B2 (en) * | 2001-10-29 | 2006-06-20 | Uniroyal Chemical Company, Inc. | Method for treating retroviral infections |
DE102008015032A1 (de) | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituierte Pyrazolamide und ihre Verwendung |
DE102008015033A1 (de) | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung |
DE102008062863A1 (de) | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung |
DE102008062878A1 (de) * | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituierte Furancarboxamide und ihre Verwendung |
CN101987842A (zh) * | 2009-07-31 | 2011-03-23 | 上海开拓者医药发展有限公司 | 一种2-甲基噻吩衍生物的制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5268389A (en) * | 1989-10-16 | 1993-12-07 | Uniroyal Chemical Company, Inc. | Thiocarboxylate ester compounds compositions containing the same |
US5968910A (en) * | 1994-11-30 | 1999-10-19 | Jan M. R. Balzarini | Compositions containing two or three inhibitors of different HIV reverse transcriptases |
-
1995
- 1995-11-30 US US08/565,493 patent/US5696151A/en not_active Expired - Lifetime
-
1996
- 1996-11-08 TW TW085113662A patent/TW448169B/zh not_active IP Right Cessation
- 1996-11-12 ZA ZA969490A patent/ZA969490B/xx unknown
- 1996-11-15 CN CN96198705A patent/CN1098847C/zh not_active Expired - Lifetime
- 1996-11-15 JP JP9520533A patent/JP3027771B2/ja not_active Expired - Lifetime
- 1996-11-15 HU HU9901990A patent/HU223660B1/hu active IP Right Grant
- 1996-11-15 DE DE69623819T patent/DE69623819T2/de not_active Expired - Lifetime
- 1996-11-15 BR BR9611838A patent/BR9611838A/pt active Search and Examination
- 1996-11-15 ES ES96942010T patent/ES2183986T3/es not_active Expired - Lifetime
- 1996-11-15 DK DK96942010T patent/DK0874839T3/da active
- 1996-11-15 PT PT96942010T patent/PT874839E/pt unknown
- 1996-11-15 KR KR10-1998-0703958A patent/KR100505841B1/ko active IP Right Grant
- 1996-11-15 AP APAP/P/1998/001245A patent/AP902A/en active
- 1996-11-15 AT AT96942010T patent/ATE224382T1/de active
- 1996-11-15 EP EP96942010A patent/EP0874839B1/en not_active Expired - Lifetime
- 1996-11-15 AU AU11199/97A patent/AU704086B2/en not_active Expired
- 1996-11-15 NZ NZ324118A patent/NZ324118A/xx not_active IP Right Cessation
- 1996-11-15 CA CA002237194A patent/CA2237194C/en not_active Expired - Lifetime
- 1996-11-15 WO PCT/US1996/018394 patent/WO1997019940A1/en active IP Right Grant
-
1998
- 1998-05-29 OA OA9800070A patent/OA10864A/en unknown
-
1999
- 1999-04-21 HK HK99101720A patent/HK1016601A1/xx not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017522334A (ja) * | 2014-07-24 | 2017-08-10 | バイエル・クロップサイエンス・アクチェンゲゼルシャフト | 殺真菌性ピラゾール誘導体 |
Also Published As
Publication number | Publication date |
---|---|
JP3027771B2 (ja) | 2000-04-04 |
EP0874839B1 (en) | 2002-09-18 |
OA10864A (en) | 2003-02-18 |
KR100505841B1 (ko) | 2005-12-14 |
DE69623819D1 (de) | 2002-10-24 |
TW448169B (en) | 2001-08-01 |
PT874839E (pt) | 2003-02-28 |
KR19990071682A (ko) | 1999-09-27 |
CA2237194C (en) | 2006-06-13 |
ES2183986T3 (es) | 2003-04-01 |
DE69623819T2 (de) | 2003-05-28 |
WO1997019940A1 (en) | 1997-06-05 |
US5696151A (en) | 1997-12-09 |
AU1119997A (en) | 1997-06-19 |
AP902A (en) | 2000-11-23 |
AP9801245A0 (en) | 1998-06-30 |
CN1098847C (zh) | 2003-01-15 |
EP0874839A1 (en) | 1998-11-04 |
ATE224382T1 (de) | 2002-10-15 |
CA2237194A1 (en) | 1997-06-05 |
ZA969490B (en) | 1997-06-02 |
HU223660B1 (hu) | 2004-11-29 |
HK1016601A1 (en) | 1999-11-05 |
DK0874839T3 (da) | 2003-01-27 |
AU704086B2 (en) | 1999-04-15 |
BR9611838A (pt) | 1999-03-09 |
HUP9901990A2 (en) | 2000-07-28 |
CN1203596A (zh) | 1998-12-30 |
HUP9901990A3 (en) | 2000-08-28 |
NZ324118A (en) | 1999-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0273451B1 (en) | Lipoxygenase inhibitory compounds | |
EP0322004B1 (en) | Cyclic anti-inflammatory derivatives of di-tert-butylphenol compounds | |
US3885038A (en) | Method of using substituted xanthone carboxylic acid | |
JPH11504657A (ja) | フラン―およびチオフェンカルボチオアミド誘導体,それらの製造,ならびにhiv―1およびhiv―1突然変異株の複製の阻害剤としてのそれらの使用 | |
GB2196962A (en) | Substituted 2-benzyl-mercapto-imidazoles and analogs useful as anti-inflammatory agents | |
KR0173455B1 (ko) | 치환된 피롤화합물 | |
EP0591046B1 (fr) | Dérivés chromeniques à chaíne triénique, utilisables dans le traitement de l'ostéoporose et des affections inflammatoires | |
EP0318090A2 (en) | Tert-butyl phenyl compounds as anti-inflammatory agents | |
JPH0379336B2 (ja) | ||
EP1220848B1 (en) | N-arymethylthioanilide compounds useful for the inhibition of the replication of hiv | |
JPS58198467A (ja) | 新規プロスタグランデイン誘導体類 | |
US4521538A (en) | Ester of the 1-methyl-5-p-toluoylpyrrole-2-acetic acid having antiinflammatory, mucolytic and antitussive properties, process for its preparation and pharmaceutical compositions containing them | |
US3891766A (en) | Methods of using substituted xanthone carboxylic acid compounds | |
JPS61172843A (ja) | 過敏症疾患治療剤としてのアリールアルコキシフエニルアリルアルコール類 | |
JPH0227355B2 (ja) | 88benzoiruaminoarukirupirorichijinjudotai | |
JP2677382B2 (ja) | ロイコトリエン拮抗剤 | |
CA1240333A (en) | Biphenylylpropionic acid derivative, process for preparing the same and pharmaceutical composition containing the same | |
JPS6033113B2 (ja) | 5−置換−2,4−ペンタジエン酸誘導体 | |
NL8603098A (nl) | 4h-benzo4,5cyclohepta1,2-bthiofeen-derivaten, farmaceutische preparaten die ze bevatten en werkwijzen voor het bereiden en toepassen van deze derivaten. | |
US4172145A (en) | Benzo(b)furylacetic acid derivatives to reduce inflammation | |
KR890002638B1 (ko) | 4H-벤조 [4, 5] 사이클로헵타 [1, 2-b] 티오펜 유도체의 제조방법 | |
US4088774A (en) | 2-Phenyl-3-(4-hydroxycoumarin-3-yl)phthalimidine | |
AU7769491A (en) | 3-naphthyl-3-carboxyalkylthio or oxy substituted alkanoic acid leukotriene antagonists | |
JPH06345752A (ja) | クマリン誘導体及びそれらの用途 | |
JPH0544450B2 (ja) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090128 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090128 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100128 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110128 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110128 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120128 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120128 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130128 Year of fee payment: 13 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140128 Year of fee payment: 14 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |